Literature DB >> 27637568

Predictive Factors for Epilepsy in Pediatric Patients With Sturge-Weber Syndrome.

Matsanga Leyila Kaseka1, Jonathan Yehouda Bitton2, Jean-Claude Décarie3, Philippe Major2.   

Abstract

BACKGROUND: Sturge-Weber syndrome is characterized by a facial port-wine stain associated with either or both a retinal angioma and a cerebral pial angioma. Because a pial angioma may not be evident on the initial imaging studies, individuals at risk for epilepsy are often not identified before their first seizure. The aim of this study is to identify predictive factors predisposing Sturge-Weber patients to epilepsy.
METHODS: The medical archives and photography database of our institution were reviewed to identify Sturge-Weber Syndrome patients followed up between 1990 and 2015. Patients without epilepsy were compared with patients with epilepsy based on the location of the port-wine stain, its extent and cerebral imaging.
RESULTS: Twenty-four patients were included in the study. Thirteen did not develop epilepsy. Patients with bilateral port-wine stain were at higher risk of epilepsy (P = 0.03). Unilateral port-wine stain did not increase the risk of epilepsy (P = 0.29) regardless of its extent. The presence of developmental venous anomalies on brain imaging was also associated with a higher risk of epilepsy (P = 0.03).
CONCLUSIONS: Bilateral facial port-wine stain and cerebral developmental venous anomalies increase the risk of epilepsy in Sturge-Weber syndrome patients. Because they can be detected at birth, they might guide preventive management and follow-up.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  GNAQ; Sturge–Weber syndrome; developmental venous anomalies; epilepsy; facial angioma; port-wine stain; predictive factors

Mesh:

Year:  2016        PMID: 27637568     DOI: 10.1016/j.pediatrneurol.2016.08.009

Source DB:  PubMed          Journal:  Pediatr Neurol        ISSN: 0887-8994            Impact factor:   3.372


  6 in total

1.  Role of the cerebral ultrasound in a case of Sturge-Weber syndrome.

Authors:  Ana Ferraz; Sofia Morais; Gabriela Mimoso
Journal:  BMJ Case Rep       Date:  2019-04-08

2.  Multicenter Research Data of Epilepsy Management in Patients With Sturge-Weber Syndrome.

Authors:  Lindsay F Smegal; Alison J Sebold; Adrienne M Hammill; Csaba Juhász; Warren D Lo; Daniel K Miles; Angus A Wilfong; Alex V Levin; Brian Fisher; Karen L Ball; Anna L Pinto; Anne M Comi
Journal:  Pediatr Neurol       Date:  2021-03-05       Impact factor: 4.210

3.  Predicting and Preventing Epilepsy in Sturge-Weber Syndrome?

Authors:  Csaba Juhász
Journal:  Pediatr Neurol Briefs       Date:  2016-11

4.  Imaging of Glutamate Concentration in Sturge-Weber Syndrome.

Authors:  Tracy S Gertler; Cynthia V Stack
Journal:  Pediatr Neurol Briefs       Date:  2017-01

5.  Study protocol: retrospectively mining multisite clinical data to presymptomatically predict seizure onset for individual patients with Sturge-Weber.

Authors:  Pooja Vedmurthy; Anna L R Pinto; Doris D M Lin; Anne M Comi; Yangming Ou
Journal:  BMJ Open       Date:  2022-02-04       Impact factor: 2.692

Review 6.  Consensus Statement for the Management and Treatment of Port-Wine Birthmarks in Sturge-Weber Syndrome.

Authors:  Sara Sabeti; Karen L Ball; Craig Burkhart; Lawrence Eichenfield; Esteban Fernandez Faith; Ilona J Frieden; Roy Geronemus; Deepti Gupta; Andrew C Krakowski; Moise L Levy; Denise Metry; J Stuart Nelson; Megha M Tollefson; Kristen M Kelly
Journal:  JAMA Dermatol       Date:  2021-01-01       Impact factor: 10.282

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.